Bitar, the current chief executive officer of Genus Plc, will join ConvaTec months after Paul Moraviec stepped down as the company's CEO last October following warnings of lower sales and profitability. (https://bit.ly/2YnfsKb)

The medical devices maker in February reported "disappointing" annual results and had launched a turnaround plan, which would include a $150 million investment over three years to boost sales and profit.

ConvaTec did not immediately respond to a Reuters request for comment.

(Reporting by Akshay Balan in Bengaluru; Editing by Lisa Shumaker)